Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2017-11-10 (8 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ARRAS (62000), Pas-de-Calais
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DONDEYNE VINCENT : revenue, balance sheet and financial ratios
PHARMACIE DONDEYNE VINCENT is a French company
founded 8 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ARRAS (62000),
this company of category PME
shows in 2022 a revenue of 1.4 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DONDEYNE VINCENT (SIREN 833233489)
Indicator
2024
2023
2022
2021
2020
2019
Revenue
N/C
N/C
1 412 353 €
N/C
N/C
N/C
Net income
52 942 €
45 714 €
102 365 €
75 431 €
68 927 €
111 254 €
EBITDA
N/C
N/C
138 784 €
N/C
N/C
N/C
Net margin
N/C
N/C
7.2%
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE DONDEYNE VINCENT generates positive net income of 53 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2024: 111 k€ -> 53 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
52 942 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 76%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 47%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
75.699%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
47.481%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DONDEYNE VINCENT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
2024
Debt ratio
190.98
145.646
133.874
139.306
104.055
75.699
Financial autonomy
29.657
34.061
35.444
32.966
40.743
47.481
Repayment capacity
None
None
None
3.766
None
None
Cash flow / Revenue
None%
None%
None%
7.584%
None%
None%
Sector positioning
Debt ratio
75.72024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average-10 pts over 3 years
In 2024, the debt ratio of PHARMACIE DONDEYNE VINCENT (75.70) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
47.48%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average+16 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DONDEYNE VINCENT (47.5%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
3.77 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of PHARMACIE DONDEYNE VINCENT (3.77) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 201.59. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
201.587
Liquidity indicators evolution PHARMACIE DONDEYNE VINCENT
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2019
2020
2021
2022
2023
2024
Liquidity ratio
259.013
257.011
231.763
165.022
190.511
201.587
Interest coverage
None
None
None
2.102
None
None
Sector positioning
Liquidity ratio
201.592024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Good+22 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DONDEYNE VINCENT (201.59) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
2.1x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Average
In 2022, the interest coverage of PHARMACIE DONDEYNE VINCENT (2.1x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DONDEYNE VINCENT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
2024
Operating WCR
0 €
0 €
0 €
210 313 €
0 €
0 €
Inventory turnover (days)
0
0
0
30
0
0
Customer payment term (days)
0
0
0
6
0
0
Supplier payment term (days)
0
0
0
54
0
0
Positioning of PHARMACIE DONDEYNE VINCENT in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DONDEYNE VINCENT is estimated at
739 109 €
(range 514 704€ - 1 105 750€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
514k€739k€1105k€
739 109 €Range: 514 704€ - 1 105 750€
NAF 5 année 2024
Valuation method used
Net Income Multiple
52 942 €
×
14.0x
=739 109 €
Range: 514 704€ - 1 105 750€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DONDEYNE VINCENT with other companies in the same sector:
Frequently asked questions about PHARMACIE DONDEYNE VINCENT
What is the revenue of PHARMACIE DONDEYNE VINCENT ?
The revenue of PHARMACIE DONDEYNE VINCENT in 2022 is 1.4 M€.
Is PHARMACIE DONDEYNE VINCENT profitable?
Yes, PHARMACIE DONDEYNE VINCENT generated a net profit of 53 k€ in 2024.
Where is the headquarters of PHARMACIE DONDEYNE VINCENT ?
The headquarters of PHARMACIE DONDEYNE VINCENT is located in ARRAS (62000), in the department Pas-de-Calais.
Where to find the tax return of PHARMACIE DONDEYNE VINCENT ?
The tax return of PHARMACIE DONDEYNE VINCENT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DONDEYNE VINCENT operate?
PHARMACIE DONDEYNE VINCENT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart